2007 - Severe Asthma

The purpose of this Research Seminar was to bring together a group of experts and young investigators, review known data and present ongoing studies that help shed light on the mechanisms and course of severe asthma. The Research Seminar focused on the following objectives:

To discuss current knowledge and research on pathophysiological mechanisms, clinical heterogeneity and new management of severe asthma, and bring together physicians, scientists and research nurses involved in the field.
To enable young scientists and physicians from Europe to discuss with experts the potential role of inflammation and structural changes of the bronchi in the persistence and severity of asthma.
To point out the heterogeneity of the disease, including different phenotypes, and the crucial role of comorbidities interfering with a potential good control. The importance of a long-term follow-up with a clear strategy of action was emphasised.
To assess the

2007 - Severe Asthma

2023 - In Vitro Diagnostic (IVD) tests to combat antimicrobial resistance in community-acquired low-respiratory tract infections (CA-LRTI)

2024 - Sleep apnea and its consequences: from animal models to precision medicine

2019 - New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Epidemiology and Triggers of Severe Asthma

M. Gaga (Athens, Greece)

Slides

Accompanying documents

Severe Asthma: A Clinically Heterogeneous Entity

E. Bel (Amsterdam, The Netherlands)

Slides

Accompanying documents

Co-Morbidities Are Serious Confounders of Asthma in Severe Asthma

P. Godard (Montpellier, France)

Slides

Accompanying documents

Animal Models of Asthma, Inflammation and Remodeling

G. Xanthou (Athens, Greece)

Slides

Accompanying documents

Endogenous Anti-Inflammatory Mechanisms and the Role of Lipoxins

I. Vachier (Montpellier, France)

Accompanying documents

What Can Be Expected From Pathology Assessment? Or: Is Severe Asthma Still an Eosinophilic Disease?

S. Wenzel (Pittsburgh, United States of America)

Slides

Accompanying documents

Inflammatory Pathways and Mediators in the Pathogenesis of Severe Asthma

G. Joos (Ghent, Belgium)

Slides

Accompanying documents

How to Manage Severe Asthma, the Value of Inflammation Monitoring

C. Brightling (Leicester, United Kingdom)

Slides

Accompanying documents

Severe Asthma, Current Options and Limitations of Pharmacotherapy

C. Corrigan (London, United Kingdom)

Slides

Accompanying documents

Severe Asthma in Children

A. Bush (London, United Kingdom)

Slides

Accompanying documents

Summing Up: A Global Management of Severe Asthma

P. Chanez (Montpellier, France)

Slides

Accompanying documents

2007 - Severe Asthma

2007 - Severe Asthma

#{title}